← Back to Search

Let's Discuss Health Website for Prostate Cancer

N/A
Recruiting
Led By Marie-Andrée Fortin, MD
Research Sponsored by Ciusss de L'Est de l'Île de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the end of the study, up to 1.5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve communication between cancer patients and their caregivers, reduce psychological distress and help patients better understand their treatments to reduce health costs and improve outcomes. #cancer #communication #caregivers #patient

Who is the study for?
This trial is for French-speaking men comfortable with the internet, diagnosed with prostate cancer, and have access to a digital device. They should be able to give informed consent and not have any severe health issues or conditions like dementia that would impair their ability to participate.
What is being tested?
The study tests the 'Let's Discuss Health' website designed to improve communication between patients with prostate cancer and their doctors, aiming to reduce psychological distress and increase treatment adherence.
What are the potential side effects?
Since this intervention involves using a website for better communication rather than medication or medical procedures, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the end of the study, up to 1.5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of the study, up to 1.5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence to the care pathway
Dialogic rate in the exchanges during the initial patient-radiation oncologist encounter
Dialogic rate of the conversations during the end-of-treatment patient-radiation oncologist encounter
+4 more
Secondary study objectives
Change in emotional distress following the medical encounter
Frequency of themes discussed during the end-of-treatment patient-radiation oncologist encounter
Frequency of themes discussed during the initial patient-radiation oncologist encounter
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Let's Discuss Health GroupExperimental Treatment1 Intervention
Patients in this group will be encouraged to prepare each of the four medical encounters targeted in the trajectory in radiation oncology using Let's Discuss Health website, which are the initial visit, the mid-treatment visit, the end-of-treatment visit and the 3-month post-treatment visit.
Group II: Usual Care GroupActive Control1 Intervention
Patients in this group will received the usual care in the radiation oncology care pathway.

Find a Location

Who is running the clinical trial?

CHU de Quebec-Universite LavalOTHER
171 Previous Clinical Trials
109,305 Total Patients Enrolled
13 Trials studying Prostate Cancer
3,841 Patients Enrolled for Prostate Cancer
Ciusss de L'Est de l'Île de MontréalLead Sponsor
77 Previous Clinical Trials
6,043 Total Patients Enrolled
Hopital Cité de la SantéUNKNOWN

Media Library

Let's Discuss Health Group Clinical Trial Eligibility Overview. Trial Name: NCT05787145 — N/A
Prostate Cancer Research Study Groups: Let's Discuss Health Group, Usual Care Group
Prostate Cancer Clinical Trial 2023: Let's Discuss Health Group Highlights & Side Effects. Trial Name: NCT05787145 — N/A
Let's Discuss Health Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05787145 — N/A
~0 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top